v3.24.1.u1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash flows from operating activities:    
Net loss $ (26,226) $ (8,874)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization 24,504 28,166
Non-cash revenue adjustments, net (808) (2,656)
Impairments 19,685 3,754
Amortization of deferred financing costs 924 1,048
Equity-based compensation 790 526
Equity in loss of unconsolidated joint venture, net 116 123
Changes in assets and liabilities:    
Accounts receivable, net and other assets, net (2,970) (4,308)
Accounts payable, accrued expenses and other liabilities, net (4,993) (6,338)
Net cash provided by operating activities 11,022 11,441
Cash flows from investing activities:    
Capital expenditures and leasing costs (4,412) (3,138)
Return of investment from unconsolidated joint venture 461 421
Principal repayments received on notes receivable 200 0
Proceeds from the settlement of property-related insurance claims 0 250
Net cash used in investing activities (3,751) (2,467)
Cash flows from financing activities:    
Payments of deferred financing costs 0 (40)
Repurchases of common stock to settle tax obligations (162) (74)
Payments of deferred equity offering costs 0 (10)
Distributions paid (5,579) (5,664)
Other financing activities (85) (56)
Net cash used in financing activities (5,826) (5,844)
Net change in cash and cash equivalents and restricted cash 1,445 3,130
Cash and cash equivalents and restricted cash at beginning of year 57,198 55,311
Cash and cash equivalents and restricted cash at end of period 58,643 58,441
Reconciliation of Cash and Cash Equivalents and Restricted Cash    
Cash and cash equivalents at beginning of year 22,473 20,638
Restricted cash at beginning of year 34,725 34,673
Cash and cash equivalents and restricted cash at beginning of year 57,198 55,311
Cash and cash equivalents at end of period 23,618 23,755
Restricted cash at end of period 35,025 34,686
Cash and cash equivalents and restricted cash at end of period $ 58,643 $ 58,441

Source

PDF HTML
10-Q Filing
ZIP XLS HTML
XBRL